PREVALENCE OF PNEUMOCOCCAL PNEUMONIAE AND OTITIDES IN INFANTS (PROVISIONAL DATA)

PREVALENCE OF PNEUMOCOCCAL PNEUMONIAE AND OTITIDES IN INFANTS (PROVISIONAL DATA)

Show other versions (1)

<p><em>The article contains provisional data from epidemiologic study of pneumococcal opaquecommunity-acquired pneumoniae and acute otitidis mediae among children from 0 to 7 years, admitted to one of St. Petersburg children’s hospitals. Etiology definition was carried out via blood and...

Full description

Bibliographic Details
Main Authors:	S.M. Kharit, S.V. Sidorenko, A.A. Ruleva, A.L. Perova, M.O. Volkova, V.V. Gostev, S.I. Alekseenko, A.V. Orlov
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2011-01-01
Series:	Вопросы современной педиатрии
Subjects:	pneumococcal pneumonia otitis vaccination children
Online Access:	http://vsp.spr-journal.ru:80/jour/article/view/783

Similar Items

PREVALENCE OF PNEUMOCOCCAL PNEUMONIAE AND OTITIDES IN INFANTS (PROVISIONAL DATA)
by: S.M. Kharit, et al.
Published: (2011-11-01)

Modern approaches to the prevention of pneumococcal infection
by: S. M. Kharit, et al.
Published: (2015-12-01)

Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines
by: Michael Pichichero, et al.
Published: (2023-12-01)

Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea
by: Hye-Young Kim, et al.
Published: (2021-03-01)

Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children
by: Matt Wasserman, et al.
Published: (2021-06-01)

Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to Higher-Valent Options in Greek Infants
by: Sophie Warren, et al.
Published: (2023-08-01)

Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control
by: Dominic Thorrington, et al.
Published: (2018-02-01)

Modeling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico
by: Matthew Wasserman, et al.
Published: (2019-03-01)

The effect of immunization with pneumococcal conjugated vaccines on Streptococcus pneumoniae resistance patterns in acute otitis media
by: Tal Marom, et al.
Published: (2017-10-01)

Efficacy of pneumococcal vaccine in immunocompetent and immunocompromised patients
by: M. P. Kostinov, et al.
Published: (2019-11-01)

Impact of pneumococcal conjugate vaccines on healthcare utilization and direct costs for otitis media in children ≤2 years of age in two Swedish regions
by: Mark Edmondson-Jones, et al.
Published: (2022-01-01)

The Economic Burden of Pneumococcal Disease in Children: A Population-Based Investigation in the Veneto Region of Italy
by: Elisa Barbieri, et al.
Published: (2022-09-01)

Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan
by: Chun-Yi Lu, et al.
Published: (2020-08-01)

Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of acute otitis media, recurrent otitis media and tympanostomy tube insertion in children after its implementation into the national immunization program in Turkey
by: Ahmet Soysal, et al.
Published: (2020-02-01)

Divergent serotype distribution between children with otitis media and those without in the pneumococcal conjugate vaccine era
by: Chih-Ho Chen, et al.
Published: (2020-12-01)

Exploring the evidence behind the comparable impact of the pneumococcal conjugate vaccines PHiD-CV and PCV13 on overall pneumococcal disease
by: Patricia Izurieta, et al.
Published: (2022-01-01)

Immunological and Epidemiological Aspects of the Immunogenicity of Streptococcus Pneumoniae Serotype 3 Capsular Polysaccharide in Pneumococcal Vaccines
by: A. E. Zaitsev, et al.
Published: (2020-04-01)

Pneumococcal vaccination in adult patients with comorbidities: a review of the clinical practice guidelines
by: Kozlov R.S., et al.
Published: (2020-12-01)

Impact of the 10-valent pneumococcal conjugate vaccine on antimicrobial prescriptions in young children: a whole population study
by: Elias Eythorsson, et al.
Published: (2018-10-01)

Economic burden of pneumococcal disease in children in Liguria, Italy
by: Daniela Amicizia, et al.
Published: (2022-11-01)

Prevention of pneumococcal diseases in the post-seven valent vaccine era: A European perspective
by: Weil-Olivier Catherine, et al.
Published: (2012-09-01)

Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?
by: Cornelis H. van Werkhoven
Published: (2017-05-01)

Streptococcus pneumoniae Serotypes Carried by Young Children and Their Association With Acute Otitis Media During the Period 2016–2019
by: Esra Ekinci, et al.
Published: (2021-07-01)

Lessons learnt after the introduction of the seven valent-pneumococcal conjugate vaccine toward broader spectrum conjugate vaccines
by: Oana Falup-Pecurariu
Published: (2012-12-01)

Intrafamilial Transmission of Pneumococcal Acute Spontaneous Peritonitis
by: Ioanna Papadatou, et al.
Published: (2023-05-01)

Economic burden of acute otitis media, pneumonia, and invasive pneumococcal disease in children in the United States after the introduction of 13-valent pneumococcal conjugate vaccines during 2014–2018
by: Tianyan Hu, et al.
Published: (2023-04-01)

Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial
by: Amanda Jane Leach, et al.
Published: (2021-03-01)

Pneumococcal Disease: Global Disease Prevention Strategies with a Focus on the Challenges in Iraq
by: Al-Jumaili A, et al.
Published: (2023-05-01)

Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media
by: Patricia Izurieta, et al.
Published: (2022-01-01)

Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children – A randomized controlled trial
by: Xavier Sáez-Llorens, et al.
Published: (2017-06-01)

Epidemiological Aspects of Pneumococcal Meningitis in the Russian Federation
by: I. S. Koroleva, et al.
Published: (2016-10-01)

A Retrospective Database Analysis to Estimate the Burden of Acute Otitis Media in Children Aged <15 Years in the Veneto Region (Italy)
by: Elisa Barbieri, et al.
Published: (2022-03-01)

Association between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneumococcal colonization density in young Peruvian children
by: Leigh M. Howard, et al.
Published: (2023-09-01)

Strategies for pneumococcal vaccination in older adults in the coming era
by: Kei Nakashima, et al.
Published: (2024-12-01)

Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world
by: Yadong A. Cui, et al.
Published: (2017-06-01)

Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines
by: Hyunju Lee, et al.
Published: (2014-02-01)

Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
by: Kristiana Alexandrova Nikolova, et al.
Published: (2021-10-01)

Incidence of pneumococcal disease from 2003 to 2019 in children ≤17 years in England
by: Salini Mohanty, et al.
Published: (2023-01-01)

A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly Population
by: Jacob Dag Berild, et al.
Published: (2020-04-01)

CLINICAL AND EPIDEMIOLOGICAL ASSESSMENT OF THE EFFECTIVENESS OF VACCINATION OF CHILDREN AGAINST PNEUMOCOCCAL INFECTION IN THE AMUR REGION
by: A. G. Chuchalin, et al.
Published: (2016-06-01)